2020 Italy Tumor Marker Testing Analyzers and Reagents: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product-Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers
Highlights
- Comprehensive 570-page analysis of the Italian tumor marker testing market.
- Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
- Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
- Five-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories.
- Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
- Current instrumentation technologies and feature comparison of leading analyzers.
- Sales and market shares of leading suppliers.
- Emerging diagnostic technologies and their potential market applications.
- Product development opportunities.
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
- Business opportunities and strategic recommendations for suppliers.
I. INTRODUCTION
II. MARKET OVERVIEW
1. Market Overview
2. Worldwide Market Structure
3. Worldwide Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. MARKET AND TECHNOLOGY OVERVIEW
A. Cancer Statistics and Etiology
1. Breast Cancer
2. Lung Cancer
3. Colon and Rectum Cancer
4. Prostate Cancer
5. Stomach Cancer
6. Leukemia
7. Lymphoma
8. Oral Cancer
9. Skin Cancer
10. Uterine Cancer
11. Ovarian Cancer
12. Bladder Cancer
B. Major Current and Emerging Cancer Diagnostic Tests
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. Prostate-Specific Antigen (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
27. Oncogenes
Abl/abl-bcr
AIB1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
PIK3CA
PTI-1
Ras
Reg
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
Alpha-Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-Interferon
Interleukin-1 (IL-1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA
CA 72-4/TAG-72
CA
CA-242
CA-549
CAM
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen
HPA
HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130
NMP22
OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki-67
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA-1/SLX
SN10
Somatostatin
TA-90
TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
E. Personal Testing
VIII. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. COMPETITIVE PROFILES
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
II. MARKET OVERVIEW
1. Market Overview
2. Worldwide Market Structure
3. Worldwide Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. MARKET AND TECHNOLOGY OVERVIEW
A. Cancer Statistics and Etiology
1. Breast Cancer
2. Lung Cancer
3. Colon and Rectum Cancer
4. Prostate Cancer
5. Stomach Cancer
6. Leukemia
7. Lymphoma
8. Oral Cancer
9. Skin Cancer
10. Uterine Cancer
11. Ovarian Cancer
12. Bladder Cancer
B. Major Current and Emerging Cancer Diagnostic Tests
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. Prostate-Specific Antigen (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
27. Oncogenes
Abl/abl-bcr
AIB1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
PIK3CA
PTI-1
Ras
Reg
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
Alpha-Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-Interferon
Interleukin-1 (IL-1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA
CA 72-4/TAG-72
CA
CA-242
CA-549
CAM
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen
Cluster-5/5A Antigen
CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen
HPA
HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3
LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA-130
NMP22
OA-519
Opioid Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki-67
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA-1/SLX
SN10
Somatostatin
TA-90
TABA
Tachykinin
TAG
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
E. Personal Testing
VIII. CANCER DIAGNOSTICS MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. COMPETITIVE PROFILES
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
X. APPENDIX: MAJOR UNIVERSITIES AND RESEARCH CENTERS DEVELOPING CANCER DIAGNOSTIC TECHNOLOGIES AND APPLICATIONS
LIST OF TABLES
Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
Estimated Cancer Death Rates Per 100,000 Population
Laboratories Performing Tumor Marker Tests by Market Segment
Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Total Tumor Marker Test Volume Forecast by Market Segment
All Market Segments Major Tumor Marker Test Volume Forecast
Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
Commercial/Private Laboratories Marker Test Volume Forecast
Total Tumor Marker Sales Major Tumor Forecast by Market Segment
All Market Segments Major Tumor Marker Sales Forecast by Test
Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
PAP Test Volume and Diagnostics Sales Forecast by Market Segment
PSA Test Volume and Diagnostics Sales Forecast by Market Segment
S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Total Tumor Marker Sales By Major Suppliers
AFP Testing Market Diagnostics Sales by Major Supplier
CA 15-3 Testing Market Diagnostics Sales by Major Supplier
CA 19-9 Testing Market Diagnostics Sales by Major Supplier
CA 125 Testing Market Diagnostics Sales by Major Supplier
CEA Testing Market Diagnostics Sales by Major Supplier
NSE Testing Market Diagnostics Sales by Major Supplier
PAP Testing Market Diagnostics Sales by Major Supplier
PSA Testing Market Diagnostics Sales by Major Supplier
Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Test Volume and Sales Forecast by Market Segment
Estimated Cancer Death Rates Per 100,000 Population
Laboratories Performing Tumor Marker Tests by Market Segment
Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Total Tumor Marker Test Volume Forecast by Market Segment
All Market Segments Major Tumor Marker Test Volume Forecast
Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
Commercial/Private Laboratories Marker Test Volume Forecast
Total Tumor Marker Sales Major Tumor Forecast by Market Segment
All Market Segments Major Tumor Marker Sales Forecast by Test
Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
PAP Test Volume and Diagnostics Sales Forecast by Market Segment
PSA Test Volume and Diagnostics Sales Forecast by Market Segment
S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Total Tumor Marker Sales By Major Suppliers
AFP Testing Market Diagnostics Sales by Major Supplier
CA 15-3 Testing Market Diagnostics Sales by Major Supplier
CA 19-9 Testing Market Diagnostics Sales by Major Supplier
CA 125 Testing Market Diagnostics Sales by Major Supplier
CEA Testing Market Diagnostics Sales by Major Supplier
NSE Testing Market Diagnostics Sales by Major Supplier
PAP Testing Market Diagnostics Sales by Major Supplier
PSA Testing Market Diagnostics Sales by Major Supplier